Xu fei
Zhengzhou, Henan, 210095, China
NCT Number: NCT06875362
Evaluate the efficacy and safety of LR08 as a dietary supplement compared to a placebo in enhancing intestinal health and immune function in healthy adults.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Interventional
Not applicable
Zhengzhou, Henan, 210095, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).
The trial period of this study lasts for 2 months(8weeks), during which each participant will have 3 visits (at month 0, month 1, andmonth 2).
Time frame: Week 0 and Week 8
Evaluation of immune function markers, specifically immunoglobulin A (IgA) concentration, to assess the effects of LR08 supplementation compared to placebo.
Looking for future studies?
Notify MeWecare Probiotics Co., Ltd.
Industry
Safety and Efficacy of LR08 in Modulating Gut Microbiota and Improving Metabolic Health in Healthy Adults: A Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06272747
Healthy Adults
Beijing, China
View Trial DetailsNCT06236841
Healthy Adults
Beijing, Beijing Municipality, China
View Trial DetailsNCT06902571
Healthy Adults
Hong Kong, Hung Hom
View Trial DetailsNCT06635161
Healthy Adults
Hong Kong, Hung Hom, Kowloon
View Trial Details